Repaglinide

CHEMBL1272 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

452.6 g/mol

LogP

5.2

Phase

4

A short-acting insulin secretagogue used to control blood sugar levels in type 2 diabetes by stimulating the pancreas to release insulin specifically around mealtimes. It is taken before each meal and its rapid action helps reduce post-meal blood sugar spikes.

Moleküler Ağırlık

452,6000 g/mol

LogP

5,20

TPSA

78,90 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Ovarian Cancer Cardiovascular Disease Rheumatoid Arthritis Melanoma Chronic Kidney Disease Stroke Obesity Lymphoma Type 2 Diabetes Hypertension Gout Malaria Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O

InChI

InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1

Molecular Formula

C27H36N2O4

HBD / HBA

2 / 5

Döndürülebilir Bağlar

10

Ağır Atomlar

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A short-acting insulin secretagogue used to control blood sugar levels in type 2 diabetes by stimulating the pancreas to release insulin specifically around mealtimes. It is taken before each meal and its rapid action helps reduce post-meal blood sugar spikes.

Yes, Repaglinide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1272. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 65981. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Repaglinide PillFYI'da

Yapı

Hızlı Veriler

Formül: C27H36N2O4
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.